Edwards Lifesciences | EW - 流动负债

股票价格

84.15

每天变化

4.43 5.56%

每月一次

1.79%

每年

10.67%

Q2 预测

82.35

金融业

USD

USD 13.7B

现金及等价物

USD 2.4B

USD 362.6M

USD 6.74B

USD 1.81B

USD 600M

USD 514.7M

USD 70.1M

15.8K

EPS每股收益

USD 0.78

股本和储备

USD 10.34B

USD 1.29B

债务利息支出

USD 35.9M

USD 56.3M

USD 600M

USD 49.08B

USD 380.7M

USD 1.13B

USD 514.7M

普通股股本

USD 580.7M

26.87

USD 348.4M

USD 1.65B

销售和管理费用

USD 522.2M

USD 1.13B

贸易债权人

USD 227.5M

应收帐款人

USD 912.1M

	流动负债	更改		日
Abbott	USD 16.5B		1.91B	2025-12
Artivion	USD 101.56M		15.72M	2025-12
AtriCure	USD 81.52M		3.68M	2025-12
Baxter International	USD 2.97B		805M	2025-12
Becton, Dickinson and Co.	USD 8.76B		448M	2025-12
Boston Scientific	USD 5.44B		111M	2025-12
Cooper Companies	USD 1.6B		482.9M	2025-12
Dexcom	USD 2.14B		1.19B	2025-12
Edwards Lifesciences	USD 1.81B		225.7M	2025-12
Globus Medical	USD 498.5M		32.54M	2025-12
ICU Medical	USD 498.86M		5.96M	2025-12
Inogen	USD 64.94M		2.12M	2025-09
Insulet	USD 680.1M		32.4M	2025-12
Integra LifeSciences	USD 455.98M		91.93M	2025-12
Intuitive Surgical	USD 2.51B		3.2M	2026-03
J&J	USD 57.72B		3.59B	2026-03
Masimo	USD 371.6M		1.9M	2025-12
Medtronic	USD 9.5B		440M	2025-12
Merit Medical Systems	USD 239.76M		9.29M	2025-12
Stryker	USD 7.79B		380M	2025-12
Tandem Diabetes Care	USD 242.72M		9.82M	2025-12
Teleflex	USD 762.03M		11.01M	2025-12
Zimmer Biomet Holdings	USD 2.58B		180.8M	2025-12